Skip to content

Diagnostic Performance and Cost-Effectiveness Analysis of AI-Based Anatomical Landmark Recognition in Upper Endoscopy

Diagnostic Performance and Cost-Effectiveness Analysis of AI-Based Anatomical Landmark Recognition in Upper Endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1032260188
Enrollment
200
Registered
2026-06-03
Start date
2026-06-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Neoplasms Neoplasm, Stomach

Interventions

Subjects undergoing screening EGD will be randomly assigned to two groups to evaluate the diagnostic performance of "Landmark Photo Checker (LMPC)", an endoscopic AI software function implemented in C
D005773
Artificial Intelligence, Endoscopic AI, Esophagogastroduodenoscopy, Quality Control, Landmark Photo Checker

Sponsors

Sonoda Takayoshi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects aged 20 years or older. Individuals undergoing upper gastrointestinal endoscopy (EGD) screening at the Cancer Screening Center, Cancer Institute Hospital of JFCR. Subjects who have provided written informed consent voluntarily after receiving a full explanation regarding participation in this study.

Exclusion criteria

Exclusion criteria: Subjects with a history of gastric resection. Individuals with distinct clinical gastrointestinal symptoms. Other individuals judged to be inappropriate for participation in this study by the principal investigator or sub-investigators.

Design outcomes

Primary

MeasureTime frame
Sensitivity of the endoscopic AI software function, Landmark Photo Checker (LMPC), in automatically judging appropriate imaging for seven anatomical landmarks during esophagogastroduodenoscopy (EGD)

Secondary

MeasureTime frame
pecificity and accuracy of the endoscopic AI software function, Landmark Photo Checker (LMPC), in automatically judging appropriate imaging for seven anatomical landmarks during esophagogastroduodenoscopy (EGD). Cost-effectiveness (5-year average costs and net monetary benefit: NMB) of implementing LMPC in gastric cancer screening using a microsimulation model based on the clinicopathological characteristics of detected and false-negative gastric cancers

Contacts

Public ContactTakayoshi Sonoda

Cancer Institute Hospital of JFCR

takayoshi.sonoda@jfcr.or.jp+81-3-3520-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026